Objective—To characterize pharmacokinetics and pharmacodynamics of detomidine gel administered sublingually in accordance with label instructions to establish appropriate withdrawal guidelines for horses before competition. Animals—12 adult racehorses. Procedures—Horses received a single sublingual administration of 0.04 mg of detomidine/kg. Blood samples were collected before and up to 72 hours after drug administration. Urine samples were collected for 5 days after detomidine administration. Plasma and urine samples were analyzed via liquid chromatography–mass spectrometry, and resulting data were analyzed by use of noncompartmental analysis. Chin-to-ground distance, heart rate and rhythm, glucose concentration, PCV, and plasma protein concentration were also assessed following detomidine administration. Results—Mean ± SD terminal elimination half-life of detomidine was 1.5 ± 1 hours. Metabolite concentrations were below the limit of detection (0.02, 0.1, and 0.5 ng/mL for detomidine, carboxydetomidine, and hydroxydetomidine, respectively) in plasma by 24 hours. Concentrations of detomidine and its metabolites were below the limit of detection (0.05 ng/mL for detomidine and 0.10 ng/mL for carboxydetomidine and hydroxydetomidine) in urine by 3 days. All horses had various degrees of sedation after detomidine administration. Time of onset was ≤ 40 minutes, and duration of sedation was approximately 2 hours. Significant decreases, relative to values at time 0, were detected for chin-to-ground distance and heart rate. There was an increased incidence and exacerbation of preexisting atrioventricular blocks after detomidine administration. Conclusions and Clinical Relevance—A 48-hour and 3-day withdrawal period for detection in plasma and urine samples, respectively should be adopted for sublingual administration of detomidine gel.

A monitoring program for melamine in milk and feed was conducted in response to global melamine alertness in the year 2008. Two screening methods were adopted i.e., a liquid chromatography triple quadrupole tandem mass spectrometry (LC-MS/MS) and enzyme-linked
immunosorbent assay (ELISA). The liquid chromatography method developed by several international research centers was adapted. This method consisted of an initial extraction with 10%trichloroacetic acid (TCA) for milk samples or 60% methanol/water for feed samples, followed by a series of centrifugation, dilution and filtration steps. Melamine was analysed in the chromatographic program using a zwitterionic HILIC LC column. Electrospray ionisation in positive ion mode was used. The quantity of melamine
present was determined with a calibration curve consisting of sample extracts from milk or feed fortified from 25 to 50 ppb that were taken through the extraction procedure. The ranges of recovery from
fortified raw milk samples (n=20) and feed samples (n=21) was 70–80% and 68%, respectively. The limit of detection was estimated at 10 ppb for both matrixes. Milk samples were found negative for melamine,
however 4.5% of feed samples were found to contain the compound at concentrations between 1 to 5 ppm.